Legal Representation
Attorney
Enshan Hong
Application History
18 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Jul 9, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 9, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jul 9, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jul 9, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jul 9, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jul 9, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jun 25, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 25, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Jun 21, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jun 21, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jun 20, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 20, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jun 20, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Jun 20, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
Jan 16, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Jan 16, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Jan 16, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
Jan 16, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 042
Consulting services in the field of pharmaceutical research and development; Pharmaceutical research and development; Pharmaceutical research and development of drugs targeting mitochondrial proteins or processes; Laboratory research services relating to pharmaceuticals; Pharmaceutical research services; Research and development in the pharmaceutical and biotechnology fields; Pharmaceutical research and development of drugs to boost mitochondrial function or reduce oxidative stress; Bioorganic chemistry research
Additional Information
Design Mark
The mark consists of stylized text of “ICM Therapeutics” and “Innovative Chemistries for Mitochondria Therapeutics” underneath, with “ICM” being in a reddish-orange color, “Therapeutics" and “ Innovative Chemistries for Mitochondria Therapeutics “ being in a light gray color, and circular icon to the text depicting a stylized representation of a mitochondrion, which features: a gray outer circle resembling a cell or membrane, a smaller inner circle in a lighter gray, symbolizing a cell's internal structure, and a curved, reddish-orange line with a pill-like shape at one end, positioned within the gray circles, suggesting mitochondria or therapeutic innovation.
Design Mark
The mark consists of stylized text of “ICM Therapeutics” and “Innovative Chemistries for Mitochondria Therapeutics” underneath, with “ICM” being in a reddish-orange color, “Therapeutics" and “ Innovative Chemistries for Mitochondria Therapeutics “ being in a light gray color, and circular icon to the text depicting a stylized representation of a mitochondrion, which features: a gray outer circle resembling a cell or membrane, a smaller inner circle in a lighter gray, symbolizing a cell's internal structure, and a curved, reddish-orange line with a pill-like shape at one end, positioned within the gray circles, suggesting mitochondria or therapeutic innovation.
Color Claim
The color(s) orange, gray is/are claimed as a feature of the mark.
Color Claim
The color(s) orange, gray is/are claimed as a feature of the mark.
Classification
International Classes
042